['lizbeth]

My impatience shows but I'm very grateful that you have the opportunity to take Neratinib. A new treatment is a wonderful blessing.

We've come along way from only mustard gas!

What is going on at Stanford? My friend who recently passed from ovarian cancer went there for the PARP inhibitors. She was highly ER+ and I don't believe this was addressed in the study. It worked amazing at first, but I think the cancer realized that the ER pathway was wide open. She did not follow traditional treatments and opted for alternatives at a time that chemo might have been the best Hail Mary.

You know how I love, love, love clinical trials. And when the day arrives that more studies do not involve chemotherapy I will be ecstatic!